Oramed Pharmaceuticals Inc. (ORMP)

NASDAQ

$4.24

$-0.04

(-0.93%)

Regular Market

Oramed Pharmaceuticals Inc. (ORMP) Live Price Chart

Last updated: ⁦2026-10-13 13:46:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Oramed Pharmaceuticals Inc. (ORMP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.24, with a market capitalisation of $180.12M and a P/E ratio of 1.02. Over the past 52 weeks, its price has ranged from $2.09 to $5.47. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$180.12M
Open	$4.28
Day's High	$31.73
Day's Low	$1.67
Previous Close	$4.27
Volume	10.50K
Average Volume	188.48K
P/E Ratio	1.02
52-Week High	$5.47
52-Week Low	$2.09
Dividend Yield	5.88%
Earnings Date	--

Oramed Pharmaceuticals Inc. (ORMP) Stock Price Today

Oramed Pharmaceuticals Inc. (ORMP) is currently trading at $4.24 as of 2026-10-13 13:45:00, down 0.70% ($0.03) from the previous close of $4.27

During today's regular trading session, ORMP has traded between $1.67 and $31.73, with a trading volume of 10.50K shares. The current price is near the lower end of today's range.

Oramed Pharmaceuticals Inc. (ORMP) 7-Day Stock Price Change

Over the past seven days, Oramed Pharmaceuticals Inc. (ORMP) moved from $4.49 to $4.24, representing a decline of 5.57% ($0.25).

The stock traded between $4.15 and $4.58 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 128.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

ORMP 52-Week Price Position

Position in Range: 63.6%

52W Low$2.09

52W High$5.47

ORMP is currently trading at $4.24, placing it 63.6% of the way from its 52-week low of $2.09 to its 52-week high of $5.47. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Oramed Pharmaceuticals Inc. (ORMP)?

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

Oramed Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	13
Exchange	NASDAQ
Company Website	https://www.oramed.com

How to Buy Oramed Pharmaceuticals Inc. (ORMP) Stock on MEXC

Eligible investors can buy real shares of Oramed Pharmaceuticals Inc. (ORMP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ORMP and Place Your Order

Open the RealStocks trading page and search for ORMP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Oramed Pharmaceuticals Inc. (ORMP) stock price today?

Oramed Pharmaceuticals Inc. (ORMP) is currently trading at $ 4.24, down 0.70% ($0.03) from the previous close of $ 4.27. Intraday prices update in real time during regular trading hours.

2.Is ORMP stock going up or down today?

As of 2026-10-13 13:45:00, ORMP is trading at $ 4.24, down 0.70% ($0.03) from its previous close of $ 4.27. The stock has traded between $ 1.67 and $ 31.73 during today’s regular session. Past price movements do not guarantee future results.

3.What is ORMP pre-market price?

As of 2026-10-13 13:45:00, ORMP is trading at $ 4.28 in pre-market trading, up 0.12% ($0.01) from the previous close of $ 4.27. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ORMP after-hours price?

As of 2026-10-13 13:45:00, ORMP is trading at $ 4.27 in after-hours trading, unchanged from the regular-session close of $ 4.27. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ORMP stock trading now?

ORMP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ORMP sit relative to its 52-week high and low?

Over the past 52 weeks, ORMP has traded between a low of $ 2.09 and a high of $ 5.47. At $ 4.24, the stock is positioned 63.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Oramed Pharmaceuticals Inc. in?

Oramed Pharmaceuticals Inc. (ORMP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Oramed Pharmaceuticals Inc.'s market capitalisation and where is it listed?

Oramed Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 180.12M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ORMP valued in terms of P/E ratio and EPS?

ORMP trades at a P/E ratio of 1.02, based on trailing-twelve-month EPS of $ 4.18. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Oramed Pharmaceuticals Inc. pay a dividend?

Oramed Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.25 per share, with a current dividend yield of 5.88% based on the latest share price. Dividend policies are subject to change at the board's discretion.